NYSE : NVST
Envista Holdings Corporation — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 24.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.95B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.97B |
| Enterprise Value | 4.43B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 160.62M |
| Shares Outstanding | 160.62M |
| Shares Change (YoY) | -3.52% |
| Shares Change (QoQ) | -1.38% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 119.59% |
| Float | 159.87M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 43.04 |
| Forward PE | 15.79 |
| PS Ratio | 1.39 |
| Forward PS | 1.37 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 36.29 |
| P/FCF Ratio | 16.02 |
| P/OCF Ratio | 13.13 |
| PEG Ratio | 1.08 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 46.70 |
| EV / Sales | 1.55 |
| EV / EBITDA | 10.92 |
| EV / EBIT | 15.25 |
| EV / FCF | 17.88 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.43 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 3.47 |
| Debt / FCF | 6.40 |
| Interest Coverage | 8.22 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.06% |
| Return on Assets (ROA) | 3.23% |
| Return on Invested Capital (ROIC) | 3.31% |
| Return on Capital Employed (ROCE) | 6.07% |
| Weighted Average Cost of Capital (WACC) | 6.78% |
| Revenue Per Employee | $238,042 |
| Profits Per Employee | $7,917 |
| Employee Count | 12,000 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.45 |
Taxes
| Measure | Value |
|---|
| Income Tax | 139.10M |
| Effective Tax Rate | 59.42% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +21.43% |
| 50-Day Moving Average | 24.55 |
| 200-Day Moving Average | 25.74 |
| Relative Strength Index (RSI) | 57.43 |
| Average Volume (20 Days) | 2,950,983 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.77M |
| Short Previous Month | 10.21M |
| Short % of Shares Out | 6.09% |
| Short % of Float | 6.11% |
| Short Ratio (days to cover) | 3.29 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.86B |
| Gross Profit | 1.58B |
| Operating Income | 290.90M |
| Pretax Income | 234.10M |
| Net Income | 95.00M |
| EBITDA | 406.20M |
| EBIT | 290.90M |
| Earnings Per Share (EPS) | $0.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 1.59B |
| Net Cash | -462.40M |
| Net Cash Per Share | -$2.88 |
| Equity (Book Value) | 3.08B |
| Book Value Per Share | 19.16 |
| Working Capital | 1.15B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 302.60M |
| Capital Expenditures | -54.50M |
| Depreciation & Amortization | 115.30M |
| Net Borrowing | n/a |
| Free Cash Flow | 248.10M |
| FCF Per Share | $1.54 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.42% |
| Operating Margin | 10.18% |
| Pretax Margin | 8.20% |
| Profit Margin | 3.33% |
| EBITDA Margin | 14.22% |
| EBIT Margin | 10.18% |
| FCF Margin | 8.69% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.52% |
| Shareholder Yield | 3.52% |
| Earnings Yield | 2.32% |
| FCF Yield | 6.24% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $28.69 |
| Price Target Difference | 16.11% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 4.49% |
| EPS Growth Forecast (3Y) | 14.98% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.74 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |